Guangzhou Hexin Instrument (SH:688622) 仪器信息网·2025-07-14 03:33Core Viewpoint - HeXin Instrument has announced the transfer of its 5.3491% equity stake in Anyeep for a total price of 17.6519 million yuan, indicating a strategic move to optimize its asset structure and focus on its core business [2][4]. Summary by Sections Equity Transfer Details - HeXin Instrument will transfer its 5.3491% stake in Anyeep, corresponding to a registered capital of 386,700 yuan, to two entities: Changzhou Huada Songhe Venture Capital Partnership (Limited Partnership) and Suzhou Jingyou Management Consulting Partnership (Limited Partnership) [4]. - The stake will be divided as follows: Huada Songhe will acquire 3.0303% for 10 million yuan, and Jingyou will acquire 2.3188% for 7.6519 million yuan [4]. Financial Implications - The transaction is based on Anyeep's current market valuation and future development prospects, approved by the board and supervisory committee without requiring shareholder approval [4]. - HeXin Instrument expects a positive impact on its comprehensive income post-transaction, subject to audit results [4][5]. Company Background - Anyeep specializes in the research and manufacturing of chemical analysis and medical testing instruments, focusing on mass spectrometry technology [5]. - As of the end of 2024, Anyeep reported total assets of approximately 95.9899 million yuan, with annual revenue of 41.8749 million yuan and a net loss of 4.8234 million yuan [5]. Strategic Intent - The sale aims to optimize HeXin Instrument's asset structure and concentrate on its main business, with no significant impact on its operations or consolidated financial statements [5].